A new computational study reports the design and in-silico evaluation of a chimeric antimicrobial peptide fusing LL-37 and ...

ProQR Therapeutics N.V. announced upcoming presentations highlighting clinical and preclinical progress with AX-0810 and ...

AI-driven protocols, adaptive trials, synthetic control arms and Asia-Pacific expansion can cut costs, reduce screening failures and accelerate oncology studies.Dublin, Oct. (GLOBE NEWSWIRE) -- ...

AI-based platforms improve trial efficiency, recruitment and monitoring, while strategic acquisitions and investments expand real-world evidence capabilities.Dublin, Oct. (GLOBE NEWSWIRE) -- "AI-based ...

United Therapeutics Corporation (NASDAQ:UTHR) has received clearance from the U.S. Food and Drug Administration (FDA) to ...

Parexel’s Stacy Hurt draws on her experience with chemotherapy and as a caregiver to spot patient burdens that AI-assisted ...

ProQR to present its ADAR-mediated RNA editing approach and progress toward next-generation editing oligonucleotides at TIDES Europe plenary ...

When the Michael J. Fox Foundation for Parkinson’s Research launched a major study in 2010, the objective was to help ...

Drug development is a stepwise process, with each clinical phase answering a different question about a treatment's safety ...

Vera Health raises $28.5M in Series A funding led by Threshold Ventures to scale its evidence-graded clinical AI search ...

"Dosing the first patient in the Corventis clinical trial is a milestone for Atrium and, more importantly, for the PRKAG2 community. This is the first clinical trial for people living with PRKAG2 ...

The University of Texas at Austin unveiled Tuesday a unified academic health system, called UT Dell Medicine, that brings its ...